glp 1 benefits and risks Why do patients stop GLP-1 drugs? GLP-1 Medicines (Ozempic and Mounjaro)

Modern IV infusion therapy grew in popularity from the original Myers cocktail developed by John Myers, MD, and adapted for todays wellness clinics

In 2025, 36% of employers offered to cover GLP-1 drugs as a treatment for both obesity and diabetes, with about 55% covering diabetes alone

Melasma: Updates and perspectives

The clinical evidence on visceral fat reduction is dramatically different

All source data underlying the graphs and charts presented in the main figures are available in the Supplementary Data 1

Acknowledgements The authors thank Ccile Desjobert, Ph.D and Marielle Romet, Ph.D (Synergy Pharm) who provided medical writing assistance funded by Laboratoires dermatologiques Avne